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Case Report
INTRODUCTION
Palatal myoclonus is a movement disorder in which there are 
rhythmic jerky movements of the soft palate. It is generally clas-
sified as somatosound or objective tinnitus and is rare compared 
to sensorineural tinnitus or subjective tinnitus. According to eti-
ologic factors, platal myoclonus has been classified as two dis-
tinct forms: 1) symptomatic palatal myoclonus, which a condi-
tion that is secondary to identifiable brainstem or cerebellar dis-
ease, and 2) essential palatal myoclonus, which presents clicking 
tinnitus in the absence of a brain lesion (1). Patients with symp-
tomatic palatal myoclonus show pathologic hypertrophic degen-
eration of the inferior olive and dentate nucleus, which initiates 
rhythmic, spontaneous, synchronized discharges within the infe-
rior olive that results in a brainstem “oscillator.” In contrast to 
the known pathologic mechanism of symptomatic palatal myoc-
lonus, there are no reports of the neurophysiology of essential 
palatal myoclonus. The pathophysiologic hypothesis of this con-
dition is a spontaneous oscillator in other parts of the brainstem, 
which is related with the palate motor function (nucleus ambig-
uous-the levator palatini, facial nucleus-the median and parame-
dian muscles, and the hypoglossal nucleus-the palatopharyngeus 
and palatoglossus) (1). 
  Orofacial buccal dystonia is a focal dystonia with sustained 
spasms of the masticatory, facial or lingual muscles (2). A well-
known condition for orofacial buccal dystonia is Meige’s syn-
drome, which is a form of cranial dystonia that’s characterized 
by bilateral dystonic spasms of the facial muscles and frequently 
by bilateral dystonic spasms of other cranial muscles (2). In this 
condition, blepharospasm is a most common and disabling man-
ifestation, and it is typically associated with lower facial or oro-
mandibular dystonia. Spasms of the neck and limb muscles may 
accompany the cranial dystonia and in most cases the cause of 
spasm is unknown (idiopathic or primary). Secondary Meige’s 
syndrome is encountered in patients with focal brain or brain-
stem lesions (3). 
  We recently experienced a rare case of orofacial buccal dysto-
nia in a patient who presented to our hospital’s otolaryngology 
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department due to an annoying clicking tinnitus of the ear, and 
this patient was finally diagnosed as essential palatal myoclonus. 
To the best of our knowledge, this is the first case report of oro-
facial buccal dystonia, which predominantly presents as palatal 
myoclonus. Botulinum toxin A injection and counseling with 
psychiatric consultation relieved the disabling symptoms of the 
ear and the orofacial area. 
CASE REPORT
A 22-year-old female presented to the ear, nose and throat (ENT) 
department with an 18-month history of persistent clicking tin-
nitus and left facial pain. The patient’s tinnitus and sensation of 
involuntary palatal movement developed about one or two 
months after starting the use of a wire type orthodontic appli-
ance. There was accompanying involuntary tremor-like dystonia 
on the left side of her face and buccal area, which was unnotice-
able to other people. Clicking tinnitus and involuntary muscle 
contraction of the face and buccal area prompted the patient to 
visit several dental, ENT and neurologic clinics; a diagnosis had 
still not been made after more than a year, and this caused the 
patient stress. 
  The tinnitus and dystonic spasm with painful sensation on the 
left facial area were aggravated over time. Stressful events in her 
everyday life made the symptoms worse. The patient felt being 
rejected, sad, frustrated, depressed and even anxious because the 
painful symptoms remained undiagnosed for a long time. The 
patient’s attempts at relief included herbal medicine, acupunc-
ture and massage, but none of these treatments were successful. 
The patient also experienced symptom-related depression, anxi-
ety and insomnia, which also created much anxiety among her 
family members. The patient visited a local neurological clinic 
where she received brain magnetic resonance imaging (MRI) and 
an electromygraphic study of her face. Clonazapam was pre-
scribed without a proper diagnosis by one neurologist, but the 
symptoms were not relieved. The patient identified that the tin-
nitus was exacerbated by touching the tongue to the palate. 
  More than 18 months had passed without any definitive diag-
nosis when the patient first presented to our department. After 
a careful and long history taking under the suspicion of palatal 
myoclonus with orofacial buccal dystonia, we thoroughly exam-
ined her palate and face. When the patient touched the palate 
with the tongue, clicking tinnitus was clearly audible and this 
could be heard by people next to her as one or two rapid clicks 
per second. Symmetric bilateral contraction of the anterior mar-
gin of the soft palate that was synchronous with the patient’s 
clicking tinnitus was observed on both the oral and nasopha-
ryngosocopic examinations. Facial examination revealed weak 
blepharospasm on the left side of her eyelid. However, we could 
not detect any noticeable contractions on the buccal area, which 
is where the patient felt the most severe dystonic movement and 
pain. We again used a fiberoptic laryngoscope to detect the 
movement of the buccal muscle and finally found the subtle 
contraction of the muscles in the left upper lip and buccal mu-
cosal area. The patient also felt an involuntary movement of the 
muscles around the left nose and chin and even in the deep part 
of the left anterior neck, but there were no definite tremor-like 
motions evident on physical examination. The pure-tone, speech 
and impedance audiometry, including assessment of the static 
compliance, were normal. Brain MRI did not show any definite 
abnormal brain findings or brainstem lesion. Consultation with 
the neurologic department ruled out other neurologic disorders 
and this was confirmed by the absence of any other accompany-
ing neurologic deficits. All of this led us to diagnose the symp-
toms as essential palatal myoclonus associated with orofacial 
buccal dystonia and this was possibly triggered by the orthodon-
tic appliance. The patient refused medication for a long time as 
she had already unsuccessfully tried different types of muscle 
relaxants, 5-HT1 agonist, a Levo-dopa agent and anticonvulsants, 
which were all prescribed by another neurologist. 
  Following an ineffective 1-month course of medical therapy 
with a combination of muscle relaxant (Baclofen
®, Pacific Phar-
ma, Seoul, Korea), anticonvulsant (Rivotril
®, Rhoche Korea, 
Seoul, Korea) and anxiolytic agent (Xanapam
®, Myung In 
Pharm, Hwasung, Korea), the patient was treated with an injec-
tion of botulinum toxin A (Dysport
®, Ipsen Korea, Seoul, Korea) 
under the guidance of electromyography (EMG). EMG of the 
tensor veli palatine, orbicularis oris and orbicularis oculi muscles 
showed bursts of abnormal electrical activity (Fig. 1). Botulinum 
toxin A was injected into both sides of the tensor veli palatini 
muscles bilaterally via the mouth (15 U each) and by a nasal 
route (10 U each) (Fig. 2). The two most painful and dystonic 
movement sites on the patient’s face (the orbicularis oculi and 
oris) were selected first and EMG-guided botulinum toxin injec-
tions were performed (10–15 U). 
  Two days later, she felt decreased clicking tinnitus and a de-
creased painful sensation with dystonia on her left face. There-
fore, botulinum toxin A was injected into every point of the ab-
normal muscle contraction on the face where the patient point-
ed and this was confirmed by EMG to have been done. The in-
jected muscle area and the dose of botulinum toxin A are dem-
onstrated in Table 1. On the review at week after injection of 
botulinum toxin A, her tinnitus and muscle dystonia were mark-
edly decreased. She developed a hypernasal voice and mild fa-
cial weakness, but she was satisfied with the treatment. Indeed, 
the patient wanted to be treated again to have complete cession 
of her tinnitus and palatal muscle contraction. So, two more con-
secutive injections into the palatal muscles (30 U in total to each 
side of the tensor veli palatine muscle) and one more injection 
into the left buccal area (15 U) were done. At the same time, the 
patient received counseling, which included general information 
about brain reorganization and behavioral modification designed 
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tus and facial muscle dystonia as well. Psychiatric consultation 
proved beneficial in easing the patient’s feelings of depression 
and anxiety.
  At the 2-month follow-up, the palatal myoclonus tinnitus had 
completely stopped and this was confirmed by nasopharyngo-
scopic examination. The orofacial buccal dystonia and pain had 
decreased and what remained was tolerable. Her hypernasal 
voice and velopharyngeal insufficiency had completely disap-
peared. Her symptoms did not reappear over the next 4 months. 
Nonetheless, additional botulinum toxin injections are planned 
if her symptoms recur.  
DISCUSSION
Palatal myoclonus is known to be a cause of objective tinnitus 
and is classified as symptomatic if the dysfunction or symptoms 
are caused by a lesion of the connections between the dentate 
nucleus, red nucleus and inferior olivary nuclei (Guillain-Mollar-
et triangle) and as essential if there is no identifiable brain lesion. 
(1). Contractions of the palatal muscles, including the levator veli 
palatini muscle and tensor veli palatini muscle cause rapid open-
ing and closing of the Eustachian tube, which produces an ob-
jective clicking tinnitus that is clearly audible by the examiner. 
Palatal myoclonus should be distinguished from middle ear my-
oclonus, which is another form of objective tinnitus. In middle 
Fig. 2. Botulinum toxin injection to the M. tensor veli palatine was ac-
complished through an EMG-guided external approach (A) and an 
endoscopic approach (B). Dots that indicated the subjective dys-
tonic points were marked on the left side of the patient’s face.
A B
Table 1. Sites and dosages of the 2nd session of botulinum toxin A in-
jection
Injection site Dose (unit)
1 Transverse part of nasalis muscle 15
2  Main portion of levator lavi superioris muscle 15
3 Inferior portion of levator lavi superioris muscle 20
4  Alar part of nasalis muscle 10
5  Orbicularis oris muscle 10
6  2nd part of levator lavi superioris muscle 10
7 Levator lavi superioris muscle (inferior portion, 2nd 
part) 
10
8 Superior portion of zygomaticus major muscle 20
9 Middle portion of zygomaticus major muscle 20
10 Inferior portion of zygomaticus major muscle 10
11 Superior portion of masseter muscle 20
12 Middle portion of masseter muscle 20
13 Inferior portion of masseter muscle 20
14 Palpebral area of orbicularis oculi muscle 15
15 Mentalis muscle 20
16 Inferolateral portion of masster muscle  20
17 Levator veli palatine muscle left & right 10&15
18 Tensor veli palatine muscle left & right  20&10
19 Geniohyoid muscle 20
20 Posterior belly of digastric muscle 15
Fig. 1. The preinjection electromyogram of the M. tensor veli palatine, orbicularis oculi, and orbicularis oris showed the bursts of electrical activ-
ity with different frequencies and amplitudes. Note that the frequency and amplitude of the M. tensor veli palatine are the most prominent. 
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ear myoclonus, the sound of the tinnitus is a buzzing instead of 
clicking, and movement of the tympanic membrane rather than 
palatal tremor is evident. Treatment for middle ear myoclonus 
involves sectioning of the stapedial and tensor tympani muscles 
(4). 
  Orofacial dystonia, which is a part of oromandibular dystonia, 
has been reported by both neurologists and dentists. Making the 
diagnosis of dystonia and the distinction between the different 
focal types such as jaw dystonia, orofacial mandibular dystonia, 
tongue dystonia and cranial dystonia are purely clinical (2, 3, 5). 
Making the diagnosis is elusive in patients with unrecognized 
triggers and who present during periods of quiescence. Further, 
there is no gold standard diagnostic test or biomarker for testing 
the validity of the diagnosis. The key to establishing the correct 
diagnosis includes early detection of the presenting complaint, 
as well as having an understanding of the functional orofacial 
anatomy that is responsible for the unique clinical signs and 
symptoms. In our case, more than 18 months passed before es-
tablishing the correct diagnosis and this was followed by proper 
treatment. Only the suspicion of the possible diagnosis along 
with thorough knowledge about the disease will prevent a de-
layed diagnosis. Orofacial dystonia affects more women than 
men with a mean age of symptom onset between 31 and 58 
years (6, 7). The etiology is idiopathic in most cases of orofacial 
dystonia. Other possible etiologies are that the orofacial dysto-
nia is drug-induced or peripheral disease-induced, or it is associ-
ated with postanoxia, neurodegenerative disorder or head injury 
(8, 9). For our case, the use of an orthodontic appliance might 
have been a possible etiologic factor that triggered the orofacial 
dystonia and palatal myoclonus because the patient had a clear 
memory of her symptom onset as related to wearing the orth-
odontic appliance. Considering the previous reports about “eden-
toulous dyskinesia” (10, 11), we can suggest that a possible 
mechanism in our case is that the malaligned teeth and the orth-
odontic appliance may have caused an impairment of proprio-
ception in the oral cavity leading to brain reorganization and 
subsequent development of dystonia. We believe that the tem-
poral and anatomical association between these two events 
might be considered as the cause since our patient showed oro-
facial dystonia and palatal myoclonus immediately after using 
the fixed orthodontic appliance. Stress and emotional factors 
could be other contributing factors that reinforced the dystonia 
and palatal myoclonus. 
  The current lack of knowledge of the exact pathophysiology 
of dystonia and palatal myoclonus has made it difficult to pre-
scribe specific pharmacologic therapy. Systemic pharmacologic 
therapy consists of a wide variety of medications, including cho-
linergics, benzodiazepam, antiparkinsonism drugs, anticonvul-
sants, muscle relaxants, 5-hydroxytryptopha, levedopa and lithi-
um (1, 2, 8, 9). Surgical therapy is another option, which includes 
Eustachian tube obliteration and ventilation tube placement 
(12), dissection of the palatal muscles (13) for the palatal myoc-
lonus and detachment of the involved muscles for the orofacial 
dystonia (5). Another more widely accepted therapeutic strategy 
for palatal myoclonus and orofacial dystonia is aimed to control 
parts of the brain using botulinum toxin, which blocks somatic 
input and output through peripheral blockage of involuntary 
muscle movement (6, 14, 15). This toxin is a potent neurotoxin 
that inhibits the calcium-mediated release of acetylcholine into 
the synaptic junction, resulting in local chemical denervation 
and loss of neuronal activity in the targeted organ. It has been 
used for treating many different types of disorders that showed 
abnormal movement. Blepharospam, oromandiblar dystonia 
and hemifacial spasm are representative well known indications 
for botolum toxin injection therapy. Botolum toxin injection be-
came recognized as a potential treatment for palatal myoclonus 
in the 1990s (6, 15). The main possible side effects of botulinum 
toxin treatment are related to a neuromuscular inhibition that 
exceeds the therapeutic goal or it spreads to the muscle groups 
adjacent to the muscle that is targeted for treatment. For palatal 
myoclonus, botulium toxin injection into the palatal muscle can 
lead to symptoms like velopharyngeal insufficiency, a hyperna-
sal voice or dysphagia. To avoid or minimize side effects, the tox-
in dosage should be as high as necessary, but as low as possible. 
However, botulinum toxin injection is considered to be a safe 
and effective first line therapy. Since there is the lack of experi-
ence concerning the optimal dosage of botulinum toxin for spe-
cial cases like ours, we tried to inject less than 30 U of toxin into 
each of the problematic sites of the orofacial buccal dystonia and 
palatal muscles at a single trial. To get the proper therapeutic re-
sponse, we had to repeat the injection in four consecutive ses-
sions. The dosage guideline for botulinum toxin injection for 
treating orofacial dytonia and palatal myoclonus should be es-
tablished in the future. We present here a case of palatal myoclo-
nus associated with orofacial buccal dystonia, and this is the first 
such report in the medical literature. To establish the correct di-
agnosis for such a case, early detection of the presenting com-
plaint, as well as a thorough understanding of the functional oro-
facial anatomy that’s responsible for the unique clinical signs and 
symptoms, is necessary. In our case, injection of botulinum toxin 
into all the involved muscles was effective. We believe that coun-
seling and psychiatric care also played a role in the therapeutic 
success. Since botulinum toxin has been proven to be safe and 
effective for many neuromuscular disorders, and this was also 
seen in our case, it can be considered to be proper treatment for 
orofacial buccal dystonia and palatal myoclonus.
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